Investors sold shares of CVS Health Corporation (NYSE:CVS) on strength during trading hours on Tuesday. $53.12 million flowed into the stock on the tick-up and $77.73 million flowed out of the stock on the tick-down, for a money net flow of $24.61 million out of the stock. Of all companies tracked, CVS Health Corporation had the 20th highest net out-flow for the day. CVS Health Corporation traded up $0.46 for the day and closed at $96.90

Several research firms have issued reports on CVS. Citigroup Inc. increased their price objective on shares of CVS Health Corporation from $105.00 to $115.00 and gave the company a “neutral” rating in a report on Monday, May 9th. Vetr raised shares of CVS Health Corporation from a “hold” rating to a “buy” rating and set a $113.29 price objective on the stock in a report on Monday, April 4th. Jefferies Group increased their price objective on shares of CVS Health Corporation from $110.00 to $122.00 and gave the company a “buy” rating in a report on Thursday, May 12th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $115.00 target price (up from $110.00) on shares of CVS Health Corporation in a research report on Wednesday, May 4th. Finally, Mizuho reiterated a “buy” rating and issued a $117.00 target price (up from $104.00) on shares of CVS Health Corporation in a research report on Wednesday, May 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. CVS Health Corporation has a consensus rating of “Buy” and a consensus target price of $113.72.

The stock has a market capitalization of $104.07 billion and a P/E ratio of 21.06. The stock has a 50-day moving average price of $95.76 and a 200 day moving average price of $98.30.

CVS Health Corporation (NYSE:CVS) last announced its earnings results on Tuesday, May 3rd. The pharmacy operator reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.02. During the same period in the previous year, the firm posted $1.14 EPS. The firm earned $43.20 billion during the quarter, compared to analyst estimates of $43.01 billion. The company’s revenue for the quarter was up 18.9% compared to the same quarter last year. Analysts forecast that CVS Health Corporation will post $5.82 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 1st. Stockholders of record on Thursday, July 21st will be paid a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date is Tuesday, July 19th.

In other news, EVP Troyen A. Brennan sold 7,517 shares of the company’s stock in a transaction dated Thursday, May 5th. The shares were sold at an average price of $105.00, for a total transaction of $789,285.00. Following the completion of the transaction, the executive vice president now owns 69,601 shares of the company’s stock, valued at approximately $7,308,105. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Larry J. Merlo sold 38,247 shares of the company’s stock in a transaction dated Thursday, May 5th. The shares were sold at an average price of $105.00, for a total transaction of $4,015,935.00. Following the transaction, the chief executive officer now directly owns 280,381 shares of the company’s stock, valued at approximately $29,440,005. The disclosure for this sale can be found here.

Several hedge funds and institutional investors recently bought and sold shares of CVS. Brown Advisory Securities LLC increased its position in CVS Health Corporation by 14.8% in the fourth quarter. Brown Advisory Securities LLC now owns 10,306 shares of the pharmacy operator’s stock worth $1,006,000 after buying an additional 1,331 shares in the last quarter. NEXT Financial Group Inc increased its position in CVS Health Corporation by 1.5% in the fourth quarter. NEXT Financial Group Inc now owns 10,611 shares of the pharmacy operator’s stock worth $1,037,000 after buying an additional 155 shares in the last quarter. Sawtooth Asset Management Inc. increased its position in CVS Health Corporation by 96.0% in the fourth quarter. Sawtooth Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock worth $1,039,000 after buying an additional 5,203 shares in the last quarter. Checchi Capital Advisers LLC increased its position in CVS Health Corporation by 9.0% in the fourth quarter. Checchi Capital Advisers LLC now owns 10,701 shares of the pharmacy operator’s stock worth $1,046,000 after buying an additional 882 shares in the last quarter. Finally, WMS Partners LLC increased its position in CVS Health Corporation by 1.4% in the fourth quarter. WMS Partners LLC now owns 11,098 shares of the pharmacy operator’s stock worth $1,085,000 after buying an additional 158 shares in the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.